FdaApplication
NDA 012249
Identifiers
- fda_app_no: NDA012249
Properties
| Property | Value |
|---|---|
| applicant_name | VALEANT PHARMACEUTICALS INTERNATIONAL |
| application_type | NDA |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LIBRIUM | CHLORDIAZEPOXIDE HYDROCHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| LIBRIUM | CHLORDIAZEPOXIDE HYDROCHLORIDE | 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
| LIBRIUM | CHLORDIAZEPOXIDE HYDROCHLORIDE | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CAPSULE;ORAL |
3 products